The company's mission is to design and produce advanced pharmaceuticals, including nano-drugs and controlled-release medications for both human and veterinary use.
Overview
overview of Rahesh Darou Novin, a pharmaceutical start-up
Rahesh Darou Novin, a pioneering research and development company, is at the forefront of innovative ocular drug delivery products under the brand 'OcuExtend®'
Rahesh Darou Novin, a pioneering research and development start up, is at the forefront of innovative ocular drug delivery products under the brand 'OcuExtend®' 'OcuExtend®’ addresses the challenge of delivering the desired drug concentration directly to the target site in the eye for an extended period. This extended drug delivery, introduced by the inventor, offers several advantages over traditional eye drops and ointments, including high patient acceptance, ease of use, non-invasiveness, and reduced side effects. 'OcuExtend®' can load multiple drugs, provide stable and uniform drug release, and minimize drug wastage. They are flexible, smooth, and do not cause irritation. The production costs are low, and the device for making them is accessible. 'OcuExtend®' do not require preservatives, can be stored at room temperature, and are biodegradable, eliminating the need for surgical removal. This invention improves patient compliance and satisfaction, making it a suitable option for both water-soluble and insoluble drugs. Rahesh Darou Novin’s OcuExtend® systems can administer medication for 3-30 days with a single application. These systems do not require anesthesia or sedation for administration.